The manufacturers of the two drugs to treat opioid addiction are competing fiercely for market share and drawing scrutiny from lawmakers and prosecutors.
Published: November 14, 2017 at 01:00AM
from NYT Health https://ift.tt/2yCollI
The manufacturers of the two drugs to treat opioid addiction are competing fiercely for market share and drawing scrutiny from lawmakers and prosecutors.
Published: November 14, 2017 at 01:00AM
from NYT Health https://ift.tt/2yCollI